Eicosanoids
Author:
- 1 November 1993
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 128 (11) , 1192-1196
Abstract
Eicosanoids were discovered as "prostaglandins" in the mid-1930s. The discovery that eicosanoids were ubiquitous in mammalian cells and that nonsteroidal antiinflammatory drugs worked by inhibiting enzymes that synthesized these chemicals heralded their extensive investigation in all fields of biology. Precursor fatty acids (arachidonic acids) are stored in cell phospholipids, acted on by two enzymes (cyclooxygenase and lipooxygenase) that yield prostaglandins, thromboxane, prostacyclin, and leukotrienes. Knowledge of their biochemical processes continue to unfold, but it is now believed that eicosanoids are part of a larger group of agents termed phospholipid mediators. Eicosanoids are intimately involved with cardiovascular function as well as central and peripheral vascular disease processes and ischemia. In the gastrointestinal tract, these potent lipids not only participate in many normal functions (eg, acid secretion and motility) but also in disease states (eg, inflammatory bowel disease and peptic ulcer disease). In shocklike states of sepsis and/or endotoxemia, eicosanoids have assumed a major role in many events that occur. Recently, discoveries have demonstrated that platelet-activating and tumor necrosis factors exert their effects in part through eicosanoids. The future will demonstrate these compounds to be critical not only in intracellular (molecular) events but also in the effects they produce that are far from the source of origin. (Arch Surg. 1993;128:1192-1196)Keywords
This publication has 19 references indexed in Scilit:
- Prostacyclin infusion in patients with acute myocardial infarction.Heart, 1985
- Prostacyclin for ischemic ulcers in peripheral arterial disease. A random assignment, placebo controlled studyThrombosis Research, 1985
- Prostaglandin E1 infusion in unstable angina: Effects on anginal frequency and cardiac functionAmerican Heart Journal, 1984
- Thromboxane B2, 6-keto-PGF1α, PGE2, PGF2α, and PGA1 plasma levels in arteriosclerosis obliterans: Relationship to clinical manifestations, risk factors, and arterial pathoanatomyAmerican Heart Journal, 1984
- Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart DiseaseNew England Journal of Medicine, 1981
- PROSTACYCLIN GENERATION IN ATHEROSCLEROTIC ARTERIESThe Lancet, 1979
- FEMORAL-ARTERY INFUSION OF PROSTAGLANDIN E1 IN SEVERE PERIPHERAL VASCULAR DISEASEThe Lancet, 1973
- Aspirin Selectively Inhibits Prostaglandin Production in Human PlateletsNature New Biology, 1971
- Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like DrugsNature New Biology, 1971
- On the specific vaso‐dilating and plain muscle stimulating substances from accessory genital glands in man and certain animals (prostaglandin and vesiglandin)The Journal of Physiology, 1936